An Overview of the Management of Rectal Neuroendocrine Tumours: A Case Report
DOI:
https://doi.org/10.51200/bjms.vi1.2939Keywords:
rectal neuroendocrine tumour, management, chemotherapyAbstract
Introduction: The incidence of patients with rectal neuroendocrine tumours (RNET) is on an exponential rise. This is due to the increasing awareness and improving knowledge of the disease resulting in earlier detection via colorectal cancer screening programmes. The latest guidelines suggest transanal, endoscopic or surgical treatment depending on the size, nature and stage of the tumour, with non-specific post-treatment surveillance.
Published
How to Cite
Issue
Section
License
All articles are published under the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license, enabling users to read, download, copy, distribute, and adapt the material for non-commercial purposes, provided proper credit is given to the original authors and the source. This model supports transparency, accessibility, and the global exchange of medical knowledge.

